Patient Safety Technologies Board of Directors Under Investigation by Glancy Binkow & Goldberg LLP

LOS ANGELES--()--Glancy Binkow & Goldberg LLP is investigating potential claims against the Board of Directors of Patient Safety Technologies (“Patient Safety” or the “Company”) (OTC:PSTX) related to the proposed acquisition of the Company by Stryker Corporation. The transaction is valued at approximately $120 million, or $2.22 per share.

This investigation concerns whether the Board of Directors of Patient Safety breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction.

If you are a shareholder of Patient Safety, if you have information or would like to learn more about our investigation, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067, by telephone at 310-201-9150 or Toll Free at 888-773-9224 or by email to shareholders@glancylaw.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Binkow & Goldberg LLP
Louis Boyarsky, Esquire
310-201-9150
Toll Free: 888-773-9224
shareholders@glancylaw.com

Release Summary

Los Angeles, CA – Glancy Binkow & Goldberg LLP is investigating potential claims against the Board of Directors of Patient Safety Technologies (“Patient Safety” or the “Company”) (OTC:PSTX)

Sharing

Contacts

Glancy Binkow & Goldberg LLP
Louis Boyarsky, Esquire
310-201-9150
Toll Free: 888-773-9224
shareholders@glancylaw.com